Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease Yoshiko Mizukawa, MD, PhD, Kazuhisa Hirahara, MD, PhD, Yoko Kano, MD, PhD, Tetsuo Shiohara, MD, PhD Journal of the American Academy of Dermatology Volume 80, Issue 3, Pages 670-678.e2 (March 2019) DOI: 10.1016/j.jaad.2018.08.052 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Proposed flow diagram for the diagnosis and outcome prediction of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms based on early and late scores. CMV, Cytomegalovirus; DiHS/DRESS, drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Journal of the American Academy of Dermatology 2019 80, 670-678.e2DOI: (10.1016/j.jaad.2018.08.052) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Supplemental Fig 1 Receiver operating characteristic curves and diagnostic performance of the predicted probability for detection of the later development of CMV disease and complications based on early and late scores. Journal of the American Academy of Dermatology 2019 80, 670-678.e2DOI: (10.1016/j.jaad.2018.08.052) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions